BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bacci M, Lorito N, Smiriglia A, Morandi A. Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance. Trends Cancer 2021;7:198-213. [PMID: 33281098 DOI: 10.1016/j.trecan.2020.10.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Pu Y, Huang R, Chai L, Yang H, Wang D, Wei Z, Zhan Z. Multimode evaluating the fluctuation of lipid droplets polarity in acute kidney injury and tumor models. Sensors and Actuators B: Chemical 2023;380:133343. [DOI: 10.1016/j.snb.2023.133343] [Reference Citation Analysis]
2 Zhao X, Lian X, Xie J, Liu G. Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment. Redox Biol 2023;62:102678. [PMID: 36940607 DOI: 10.1016/j.redox.2023.102678] [Reference Citation Analysis]
3 Wu S, Wang J, Fu Z, Familiari G, Relucenti M, Aschner M, Li X, Chen H, Chen R. Matairesinol Nanoparticles Restore Chemosensitivity and Suppress Colorectal Cancer Progression in Preclinical Models: Role of Lipid Metabolism Reprogramming. Nano Lett 2023;23:1970-80. [PMID: 36802650 DOI: 10.1021/acs.nanolett.3c00035] [Reference Citation Analysis]
4 Pei S, Zhang P, Yang L, Kang Y, Chen H, Zhao S, Dai Y, Zheng M, Xia Y, Xie H. Exploring the role of sphingolipid-related genes in clinical outcomes of breast cancer. Front Immunol 2023;14:1116839. [PMID: 36860848 DOI: 10.3389/fimmu.2023.1116839] [Reference Citation Analysis]
5 Ferrarini F, Zulato E, Moro M, Del Bianco P, Borzi C, Esposito G, Zanin T, Sozzi G, Indraccolo S. Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study. Front Oncol 2023;13:1070505. [PMID: 36925926 DOI: 10.3389/fonc.2023.1070505] [Reference Citation Analysis]
6 Ma X, Yu H, Wang M, Li M, Feng X, Shao M, Zhang Q, Zhong F. An imidazole-derived polarity sensitive probe for lipid droplet target and in vivo tumor imaging. Talanta 2023;252:123903. [DOI: 10.1016/j.talanta.2022.123903] [Reference Citation Analysis]
7 Moreira-barbosa C, Matos A, Fernandes R, Mendes-ferreira M, Rodrigues R, Cruz T, Costa ÂM, Cardoso AP, Ghilardi C, Oliveira MJ, Ribeiro R. The role of fatty acids metabolism on cancer progression and therapeutics development. Bioactive Lipids 2023. [DOI: 10.1016/b978-0-12-824043-4.00007-5] [Reference Citation Analysis]
8 Bezawork-Geleta A, Dimou J, Watt MJ. Lipid droplets and ferroptosis as new players in brain cancer glioblastoma progression and therapeutic resistance. Front Oncol 2022;12:1085034. [PMID: 36591531 DOI: 10.3389/fonc.2022.1085034] [Reference Citation Analysis]
9 Zeng W, Yin X, Jiang Y, Jin L, Liang W. PPARα at the crossroad of metabolic-immune regulation in cancer. FEBS J 2022;289:7726-39. [PMID: 34480827 DOI: 10.1111/febs.16181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Roh J, Im M, Chae Y, Kang J, Kim W. The Involvement of Long Non-Coding RNAs in Glutamine-Metabolic Reprogramming and Therapeutic Resistance in Cancer. Int J Mol Sci 2022;23. [PMID: 36499136 DOI: 10.3390/ijms232314808] [Reference Citation Analysis]
11 Han Z, Liu M, Xie Y, Zeng K, Zhan Z, Chen Y, Wang L, Chen X, Luo Y, Zeng Y, Zhan H, Lin Y, Zhang K, Zhu X, Liu S, Luo X, Zhou A. Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis. Cell Death Discov 2022;8:445. [DOI: 10.1038/s41420-022-01241-9] [Reference Citation Analysis]
12 Shao F, Mao H, Luo T, Li Q, Xu L, Xie Y. HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma. Front Oncol 2022;12:894485. [DOI: 10.3389/fonc.2022.894485] [Reference Citation Analysis]
13 Yin X, Xu R, Song J, Ruze R, Chen Y, Wang C, Xu Q. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Commun (Lond) 2022;42:1234-56. [PMID: 36107801 DOI: 10.1002/cac2.12360] [Reference Citation Analysis]
14 Dai W, Xiang W, Han L, Yuan Z, Wang R, Ma Y, Yang Y, Cai S, Xu Y, Mo S, Li Q, Cai G. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Cancer Commun (Lond) 2022. [PMID: 35904817 DOI: 10.1002/cac2.12341] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Wei Z, Cheng G, Ye Y, Le C, Miao Q, Chen J, Yang H, Zhang X. A Fatty Acid Metabolism Signature Associated With Clinical Therapy in Clear Cell Renal Cell Carcinoma. Front Genet 2022;13:894736. [DOI: 10.3389/fgene.2022.894736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rupert JE, Kolonin MG. Fatty acid translocase: a culprit of lipid metabolism dysfunction in disease. Immunometabolism 2022;4:e00001. [DOI: 10.1097/in9.0000000000000001] [Reference Citation Analysis]
17 Ni L, Sun P, Ai M, Kong L, Xu R, Li J. Berberine inhibited the formation of metastasis by intervening the secondary homing of colorectal cancer cells in the blood circulation to the lung and liver through HEY2. Phytomedicine 2022;104:154303. [PMID: 35802997 DOI: 10.1016/j.phymed.2022.154303] [Reference Citation Analysis]
18 Cui M, Yi X, Zhu D, Wu J. The Role of Lipid Metabolism in Gastric Cancer. Front Oncol 2022;12:916661. [DOI: 10.3389/fonc.2022.916661] [Reference Citation Analysis]
19 Cheng H, Wang M, Su J, Li Y, Long J, Chu J, Wan X, Cao Y, Li Q. Lipid Metabolism and Cancer. Life 2022;12:784. [DOI: 10.3390/life12060784] [Reference Citation Analysis]
20 Zhao YY, Wang MM, Cui JF. New progress in the mechanism of microenvironment-driven chemoradiotherapy resistance in digestive system tumors. Shijie Huaren Xiaohua Zazhi 2022; 30(8): 341-348 [DOI: 10.11569/wcjd.v30.i8.341] [Reference Citation Analysis]
21 Cerella C, Lorant A, Aquilano K, Diederich M. Editorial: Next-Generation Cancer Therapies Based on a (R)evolution of the Biomarker Landscape. Front Pharmacol 2022;13:861424. [PMID: 35330836 DOI: 10.3389/fphar.2022.861424] [Reference Citation Analysis]
22 Czekay RP, Cheon DJ, Samarakoon R, Kutz SM, Higgins PJ. Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets. Cancers (Basel) 2022;14:1231. [PMID: 35267539 DOI: 10.3390/cancers14051231] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
23 Twigger AJ, Sumbal J, Bentires-Alj M, Howard BA. Thirteenth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast Cancer. J Mammary Gland Biol Neoplasia 2022;27:233-9. [PMID: 36242657 DOI: 10.1007/s10911-022-09526-6] [Reference Citation Analysis]
24 Martín-otal C, Navarro F, Casares N, Lasarte-cía A, Sánchez-moreno I, Hervás-stubbs S, Lozano T, Lasarte JJ. Impact of tumor microenvironment on adoptive T cell transfer activity. Adoptive Cell Transfer 2022. [DOI: 10.1016/bs.ircmb.2022.03.002] [Reference Citation Analysis]
25 Masetti M, Carriero R, Portale F, Marelli G, Morina N, Pandini M, Iovino M, Partini B, Erreni M, Ponzetta A, Magrini E, Colombo P, Elefante G, Colombo FS, den Haan JM, Peano C, Cibella J, Termanini A, Kunderfranco P, Brummelman J, Chung MWH, Lazzeri M, Hurle R, Casale P, Lugli E, Depinho RA, Mukhopadhyay S, Gordon S, Di Mitri D. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. Journal of Experimental Medicine 2022;219:e20210564. [DOI: 10.1084/jem.20210564] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
26 Cai L, Ying M, Wu H. Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy. Front Oncol 2021;11:777273. [PMID: 34888248 DOI: 10.3389/fonc.2021.777273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sabnis RW. Novel Substituted Tetrazoles as ACSS2 Inhibitors for Treating Cancer. ACS Med Chem Lett 2021;12:1894-5. [PMID: 34917250 DOI: 10.1021/acsmedchemlett.1c00621] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Sabnis RW. Amide-Substituted Condensed Pyridine Derivatives as ACSS2 Inhibitors for Treating Cancer. ACS Med Chem Lett 2021;12:1870-1. [PMID: 34917239 DOI: 10.1021/acsmedchemlett.1c00571] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Ye L, Jin F, Kumar SK, Dai Y. The mechanisms and therapeutic targets of ferroptosis in cancer. Expert Opin Ther Targets 2021;:1-22. [PMID: 34821176 DOI: 10.1080/14728222.2021.2011206] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
30 Luby A, Alves-Guerra MC. Targeting Metabolism to Control Immune Responses in Cancer and Improve Checkpoint Blockade Immunotherapy. Cancers (Basel) 2021;13:5912. [PMID: 34885023 DOI: 10.3390/cancers13235912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Zeng Z, Ma C, Chen K, Jiang M, Vasu R, Liu R, Zhao Y, Zhang H. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. Cells 2021;10:2988. [PMID: 34831211 DOI: 10.3390/cells10112988] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Sun M, Wang C, Lv M, Fan Z, Du J. Mitochondrial-targeting nanoprodrugs to mutually reinforce metabolic inhibition and autophagy for combating resistant cancer. Biomaterials 2021;278:121168. [PMID: 34600158 DOI: 10.1016/j.biomaterials.2021.121168] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
33 Bosch M, Sweet MJ, Parton RG, Pol A. Lipid droplets and the host-pathogen dynamic: FATal attraction? J Cell Biol 2021;220:e202104005. [PMID: 34165498 DOI: 10.1083/jcb.202104005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
34 Brohée L, Crémer J, Colige A, Deroanne C. Lipin-1, a Versatile Regulator of Lipid Homeostasis, Is a Potential Target for Fighting Cancer. Int J Mol Sci 2021;22:4419. [PMID: 33922580 DOI: 10.3390/ijms22094419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]